Medicare Enrolled

Dr. Patrick Pavwoski, D.O.

Neurology · Muskegon, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1150 E SHERMAN BLVD, Muskegon, MI 49444
2316724243
In practice since 2013 (13 years)
NPI: 1073953881 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pavwoski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pavwoski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pavwoski

Dr. Patrick Pavwoski is a neurology specialist in Muskegon, MI, with 13 years of NPI registration. Based on federal Medicare data, Dr. Pavwoski performed 550 Medicare services across 404 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pavwoski received a total of $238,267 from 62 pharmaceutical and/or device companies across 1014 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pavwoski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 27% volume in MI $238,267 industry payments

Medicare Practice Summary

Medicare Utilization ↗
550
Medicare services
Top 27% in MI for neurology
404
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~42 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
94 $93 $181
New patient office visit, complex (60-74 min) 90 $122 $357
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
89 $132 $350
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
54 $63 $262
Facial nerve injection with anesthetic and/or steroid
An injection of an anesthetic agent and/or steroid into the facial nerve. This procedure delivers medication directly to the nerve.
51 $30 $227
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
50 $69 $187
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
44 $109 $251
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
40 $91 $310
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
14 $169 $527
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $52 $129
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
12 $62 $126
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$238,267
Total received (2018-2024)
Avg $34,038/year across 7 years
Top 6% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
1,014
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$214,338 (90.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,777 (6.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,152 (3.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,628
2023
$49,142
2022
$65,710
2021
$62,730
2020
$40,254
2019
$3,796
2018
$9,006

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$6,849
EMD Serono, Inc.
$272
Teva Pharmaceuticals USA, Inc.
$161
PFIZER INC.
$153
Otsuka America Pharmaceutical, Inc.
$44
JAZZ PHARMACEUTICALS INC.
$26
Novartis Pharmaceuticals Corporation
$24
UCB, Inc.
$22
Lundbeck LLC
$19
Biogen, Inc.
$19
Genentech USA, Inc.
$19
Kyowa Kirin, Inc.
$18
Top 3 companies account for 95.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$89,063
Allergan, Inc.
$42,318
Biogen, Inc.
$37,133
AbbVie Inc.
$27,512
Biohaven Pharmaceuticals, Inc.
$13,894
Novartis Pharmaceuticals Corporation
$6,931
Biohaven Pharmaceutical Holding Company Ltd.
$4,938
EMD Serono, Inc.
$3,234
Amgen Inc.
$1,919
Teva Pharmaceuticals USA, Inc.
$1,422
Medtronic USA, Inc.
$1,094
PFIZER INC.
$847
Allergan Inc.
$713
Lundbeck LLC
$598
UCB, Inc.
$548
Boston Scientific Corporation
$451
Lilly USA, LLC
$371
Genentech USA, Inc.
$320
US WorldMeds, LLC
$313
Alexion Pharmaceuticals, Inc.
$260
Supernus Pharmaceuticals, Inc.
$253
Janssen Pharmaceuticals, Inc
$237
GENZYME CORPORATION
$235
Genentech, Inc.
$225
E.R. Squibb & Sons, L.L.C.
$213
ACADIA Pharmaceuticals Inc
$210
Celgene Corporation
$210
EISAI INC.
$201
Eisai Inc.
$199
JAZZ PHARMACEUTICALS INC.
$196
Sunovion Pharmaceuticals Inc.
$185
UPSHER-SMITH LABORATORIES LLC
$176
Otsuka America Pharmaceutical, Inc.
$175
Neurelis, Inc.
$172
Kyowa Kirin, Inc.
$152
Acorda Therapeutics, Inc
$136
Greenwich Biosciences, Inc.
$125
AQUESTIVE THERAPEUTICS, INC.
$124
Alnylam Pharmaceuticals Inc.
$84
Avanir Pharmaceuticals, Inc.
$79
CSL Behring
$75
BOSTON SCIENTIFIC CORPORATION
$73
Neurocrine Biosciences, Inc.
$57
Medtronic, Inc.
$56
ARBOR PHARMACEUTICALS, INC.
$54
MDD US Operations, LLC
$53
Integra LifeSciences Corporation
$52
Bayer HealthCare Pharmaceuticals Inc.
$42
Upsher-Smith Laboratories LLC
$38
Takeda Pharmaceuticals U.S.A., Inc.
$37
Mitsubishi Tanabe Pharma America, Inc.
$32
Zimmer Biomet Holdings, Inc.
$32
Amneal Pharmaceuticals LLC
$28
MITSUBISHI TANABE PHARMA AMERICA, INC.
$24
GE HEALTHCARE
$23
Mallinckrodt LLC
$22
SANOFI-AVENTIS U.S. LLC
$22
RTI Surgical, Inc.
$20
Adamas Pharmaceuticals, Inc.
$18
ARGENX US, INC.
$16
TG THERAPEUTICS, INC.
$16
Ethicon US, LLC
$13
Top 3 companies account for 70.7% of all-time payments
Associated products mentioned in payments ›
1.5mm Neuro · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Allograft · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CHANTIX · CODMAN CERTAS · COMIRNATY · COPAXONE · Cellentra · ELIQUIS · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GAMMAGARD · GENERAL - THERAPIES · GILENYA · GIVLAARI · GOCOVRI · Gliadel · HUMALOG · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LINQ II · LYRICA · Leqembi · Luveris · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFIRMEV · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · PANZYGA · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SECURESTRAP · SOLIRIS · SPECTRA WAVEWRITER · SYMPAZAN · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VUMERITY · VYEPTI · VYVGART · Vimpat · XADAGO · XARELTO · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in MI.

Looking for a neurology specialist in Muskegon?
Compare neurologists in the Muskegon area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
8
Per 100K population
4.6
County median income
$63,495
Nearest hospital
TRINITY HEALTH MUSKEGON HOSPITAL
4.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pavwoski is a clinical cardiology specialist, with above-average Medicare volume (top 27% in MI), with speaking/promotional industry engagement in the top 6% of MI peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pavwoski experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Pavwoski performed 94 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pavwoski receive payments from pharmaceutical companies?
Yes. Dr. Pavwoski received a total of $238,267 from 62 companies across 1,014 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pavwoski's costs compare to other neurologists in Muskegon?
Dr. Pavwoski's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pavwoski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →